Replies to post #4139 on Invictus MD Strategies Corp (IVITF)

[the third leg]

Thank you, Ive done my dd, and I have my plan of comfort and I am thrilled about this move if approved. Especially with what they are achieving and building over the next 2 years. Unlike our new possible companies below, we will have a tremendous share structure even if they raise a bunch of cash 1 last time. Special.. and

To date, five Canadian marijuana stocks have chosen to move their listing to one of the two major U.S. exchanges.
Cronos Group (NASDAQ:CRON): Cronos Group became the first pot stock to uplist to a major exchange, in this case the Nasdaq, at the end of February. Expected to be a top-10 producer when at peak capacity, Cronos in July announced a joint venture with a group of investors that'll allow the construction of an 850,000-square-foot greenhouse capable of 70,000 kilograms of annual yield.
Canopy Growth Corp. (NYSE:CGC): Canopy Growth was planning to be the first pot stock to uplist in October 2017. Those plans changed when it received the first of what would become three investments from alcoholic beverage giant Constellation Brands. With Tweed, arguably the best known cannabis brand; superior sales channels; and production capacity that'll probably rank second overall, at around 500,000 kilograms per year at peak capacity, Canopy Growth has certainly benefited from its increased exposure.
Tilray (NASDAQ:TLRY): Though Cronos beat Tilray to the punch of listing on the Nasdaq, Tilray still made history by becoming the first Canadian marijuana stock to go the initial public offering route in the United States. Currently laying the foundation for its international expansion and capacity growth, Tilray is likely to become a top-five producer within the next three years.
Aurora Cannabis (NYSE:ACB): In October, Aurora Cannabis uplisted to the NYSE with the clear intent of attracting long-term investors. Aurora Cannabis is widely expected to be the leading producer by volume in Canada. Inclusive of its ICC Labs acquisition, and the 1.1 million square feet of capacity ICC is developing, Aurora Cannabis should easily surpass 600,000 kilograms in annual production. In other words, it very much deserves its NYSE listing.
Aphria (NYSE:APHA): Last, but not least, Aphria uplisted to the NYSE just days ago. Aphria projects to slide in as the No. 3 grower by annual yield, with an estimated 255,000 kilograms. Aphria's focus on alternative cannabis products, including its under-construction extraction center for concentrates, should play a big role in lifting its operating margin and making the company profitable.